Evaluation of Dosimetric Parameters for Tumor Therapy with ۱۷۷Lu and ۹۰Y Radionuclides in Gate Monte Carlo Code

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 31

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JBPE-11-3_001

تاریخ نمایه سازی: 30 دی 1402

Abstract:

Background: ۹۰Y and ۱۷۷Lu are two well-known radionuclides used in radionuclide therapy to treat neuroendocrine tumors. Objective: This current study aims to evaluate, compare and optimize tumor therapy with ۹۰Y and ۱۷۷Lu for different volumes of the tumor using the criterion of self-absorbed dose, cross-absorbed dose, absorbed dose profile, absorbed dose uniformity, and dose-volume histogram (DVH) curve using Gate Monte Carlo simulation code.Material and Methods: In our analytical study, Gate Monte Carlo simulation code has been used to model tumors and simulate particle transport. Spherical tumors were modeled from radius ۰.۵ to ۲۰ mm. Tumors were uniformly designed from water (soft tissue reagent). The full energy spectrum of each radionuclide of ۱۷۷Lu and ۹۰Y was used in the total volume of tumors with isotropic radiation, homogeneously. Self-absorbed dose, cross-absorbed dose, absorbed dose profile, absorbed dose uniformity, and DVH curve parameters were evaluated. Results: The absorbed dose for ۹۰Y is higher than ۱۷۷Lu in all tumors (p-value <۵%). The uniformity of the absorbed dose for ۱۷۷Lu is much greater than ۹۰Y. As the tumor size increases, the DVH graph improves for ۹۰Y. Conclusion: Based on self-absorbed dose, cross-absorbed dose, absorbed dose uniformity, and DVH diagram, ۱۷۷Lu and ۹۰Y are appropriate for smaller and larger tumors, respectively. Next, we can evaluate the appropriate cocktail of these radionuclides, in terms of the type of composition, for the treatment of tumors with a specific size.

Authors

- -

MSc, Department of Medical Physics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

- -

PhD, Department of Medical Physics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

- -

PhD, Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran

- -

MSc, Department of Medical Physics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Brans B, Linden O, Giammarile F, Tennvall J, Punt C. ...
  • Saha GB. Physics and radiobiology of nuclear medicine. Springer Science ...
  • Stigbrand T, Carlsson J, Adams GP, editors. Targeted radionuclide tumor ...
  • Zavgorodni SF. A model for dose estimation in therapy of ...
  • Zweit J. Radionuclides and carrier molecules for therapy. Phys Med ...
  • Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, ...
  • Kunikowska J, Królicki L, Hubalewska-Dydejczyk A, Mikołajczak R, Sowa-Staszczak A, ...
  • Huizing DMV, Verheij M, Stokkel MPM. Dosimetry methods and clinical ...
  • Enger SA, Hartman T, Carlsson J, Lundqvist H. Cross-fire doses ...
  • Erdi AK, Erdi YE, Yorke ED, Wessels BW. Treatment planning ...
  • Humm JL. Dosimetric aspects of radiolabeled antibodies for tumor therapy. ...
  • Spaic R, Ilic R, Dragovic M, Petrovic B. Generation of ...
  • O’Donoghue JA, Bardiès M, Wheldon TE. Relationships between tumor size ...
  • Wong FC. MIRD: radionuclide data and decay schemes. JNM. ۲۰۰۹;۵۰(۱۲):۲۰۹۱. ...
  • Khan FM, Gibbons JP. Khan’s the physics of radiation therapy. ...
  • De Jong M, Breeman WA, Valkema R, Bernard BF, Krenning ...
  • Navalkissoor S, Flux G, Bomanji J. Molecular radiotheranostics for neuroendocrine ...
  • نمایش کامل مراجع